194
Views
0
CrossRef citations to date
0
Altmetric
Rapid Communication

A New and Easier Approach to Preserflo MicroShunt Implantation

ORCID Icon, , , , &
Pages 1281-1288 | Published online: 27 Apr 2022

References

  • Ansari E. An update on implants for Minimally Invasive Glaucoma Surgery (MIGS). Ophthalmol Ther. 2017;6(2):233–241. doi:10.1007/s40123-017-0098-2
  • Bar-David L, Blumenthal EZ. Evolution of glaucoma surgery in the last 25Years. Rambam Maimonides Med J. 2018;9(3):e0024. doi:10.5041/RMMJ.10345.
  • Mathew DJ, Buys YM. Minimally invasive glaucoma surgery: a critical appraisal of the literature. Annu Rev Vis Sci. 2020;6:47–89. doi:10.1146/annurev-vision-121219-081737
  • Vinod K, Gedde SJ. Safety profile of minimally invasive glaucoma surgery. Curr Opin Ophthalmol. 2021;32(2):160–168. doi:10.1097/ICU.0000000000000731
  • Pereira ICF, van de Wijdeven R, Wyss HM, et al. Conventional glaucoma implants and the new MIGS devices: a comprehensive review of current options and future directions. Eye. 2021;35(12):3202–3221. doi:10.1038/s41433-021-01595-x
  • Lee RMH, Bouremel Y, Eames I, Brocchini S, Khaw PT. Translating minimally invasive glaucoma surgery devices. Clin Transl Sci. 2020;13(1):14–25. doi:10.1111/cts.12660
  • Pinchuk L, Wilson GJ, Barry JJ, et al. Medical applications of poly (styrene-block-isobutylene-block-styrene) (“SIBS”). Biomaterials. 2008;29(4):448–460. doi:10.1016/j.biomaterials.2007.09.041
  • Beckers JM, Pinchuk L. Minimally invasive glaucoma surgery with a new Ab-externo subconjunctival bypass – current status and review of literature. Eur Ophthal Rev. 2019;13(1):27–30. doi:10.17925/EOR.2019.13.1.27
  • Riss I, Batlle J, Pinchuk L, et al. [One-year results on the safety and efficacy of the InnFocus MicroShunt™ depending on placement and concentration of mitomycin C]. J Fr Ophtalmol. 2015;38(9):855–860. French. doi:10.1016/j.jfo.2015.05.005
  • Batlle JF, Fantes F, Riss I, et al. Three-year follow-up of a novel aqueous humor MicroShunt. J Glaucoma. 2016;25(2):e58–65. doi:10.1097/IJG.0000000000000368
  • Scheres LMJ, Kujovic-Aleksov S, Ramdas WD, et al. XEN® gel stent compared to PRESERFLO™ MicroShunt implantation for primary open-angle glaucoma: two-year results. Acta Ophthalmol. 2021;99(3):e433–e440. doi:10.1111/aos.14602
  • Batlle JF, Corona A, Albuquerque R. Long-term results of the PRESERFLO®MicroShunt in patients with primary open-angle glaucoma from a single-center non-randomized study. J Glaucoma. 2021;30(3):281–286. doi:10.1097/IJG.0000000000001734
  • Beckers H, Aptel F, Webers C, et al. Two-year results of a multicentre study assessing the MicroShunt in patients with primary open-angle glaucoma: 0.4 mg/mL mitomycin C outcomes. Poster presented at the 37th Congress of the ESCRS; 2019; Paris (France). Available from: https://www.escrs.org/paris2019/programme/posters-details.asp?id=33176. Accessed November 22, 2021.
  • Schlenker MB, Durr GM, Michaelov E, Ahmed IIK. Intermediate outcomes of a novel standalone ab externo SIBS microshunt with mitomycin C. Am J Ophthalmol. 2020;215:141–153. doi:10.1016/j.ajo.2020.02.020
  • Baker ND, Barnebey HS, Moster MR, et al.; INN005 Study Group. Ab-externomicroshunt versus trabeculectomy in primary open-angle glaucoma: one-year results from a 2-year randomized, Multicenter Study. Ophthalmology. 2021;128(12):1710–1721. doi:10.1016/j.ophtha.2021.05.023
  • Fea AM, Laffi GL, Martini E, et al. Effectiveness of MicroShunt in primary open-angle and pseudoexfoliative glaucoma patients: a retrospective European multicenter study. Ophthalmol Glaucoma. 2021. doi:10.1016/j.ogla.2021.08.005
  • Albis-Donado O, Gil-Carrasco F, Romero-Quijada R, Thomas R. Evaluation of Ahmed glaucoma valve implantation through a needle-generated scleral tunnel in Mexican children with glaucoma. Indian J Ophthalmol. 2010;58(5):365–373. doi:10.4103/0301-4738.67039
  • Leong JK, McCluskey P, Lightman S, Towler HM. Outcome of graft free Molteno tube insertion. Br J Ophthalmol. 2006;90(4):501–505. doi:10.1136/bjo.2005.079087